A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: The “Folded melody valve”

2014 ◽  
Vol 85 (4) ◽  
pp. 604-610 ◽  
Author(s):  
Zakaria Jalal ◽  
Sophie Malekzadeh-Milani ◽  
Michael Hofbeck ◽  
Khalid Al Najashi ◽  
Jean-Benoit Thambo ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Pulmonary Valve ◽  
Implantation Technique ◽  
Melody Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

scholarly journals Early Outcomes of Percutaneous Pulmonary Valve Implantation with Pulsta and Melody Valves: The First Report from Korea

2020 ◽  
Vol 9 (9) ◽  
pp. 2769
Author(s):  
Ah Young Kim ◽  
Jo Won Jung ◽  
Se Yong Jung ◽  
Jae Il Shin ◽  
Lucy Youngmin Eun ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Pulmonary Valve ◽  
Pulmonary Regurgitation ◽  
Systolic Pressure ◽  
Volume Index ◽  
Melody Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

Percutaneous pulmonary valve implantation (PPVI) is used to treat pulmonary stenosis (PS) or pulmonary regurgitation (PR). We described our experience with PPVI, specifically valve-in-valve transcatheter pulmonary valve replacement using the Melody valve and novel self-expandable systems using the Pulsta valve. We reviewed data from 42 patients undergoing PPVI. Twenty-nine patients had Melody valves in mostly bioprosthetic valves, valved conduits, and homografts in the pulmonary position. Following Melody valve implantation, the peak right ventricle-to-pulmonary artery gradient decreased from 51.3 ± 11.5 to 16.7 ± 3.3 mmHg and right ventricular systolic pressure fell from 70.0 ± 16.8 to 41.3 ± 17.8 mmHg. Thirteen patients with native right ventricular outflow tract (RVOT) lesions and homograft underwent PPVI with the new self-expandable Pulsta valve—a nitinol wire stent mounted with a trileaflet porcine pericardial valve. Following Pulsta valve implantation, cardiac magnetic resonance imaging showed a decreased PR fraction and that the right ventricular end-diastolic volume index decreased from 166.1 ± 11.9 to 123.6 ± 12.4 mL/m2. There were no mortality, severe procedural morbidity, or valve-related complications. At the mean 14.2 month (4–57 months) follow-up, no patients had more than mild PR. PPVI using Melody and Pulsta valves was first shown to provide excellent early outcomes without serious adverse event in most patients with RVOT dysfunction in Korea.

scholarly journals Mid-Term Outcomes Following Percutaneous Pulmonary Valve Implantation Using the “Folded Melody Valve” Technique

2021 ◽  
Vol 14 (4) ◽  
Author(s):  
Zakaria Jalal ◽  
Estíbaliz Valdeolmillos ◽  
Sophie Malekzadeh-Milani ◽  
Andreas Eicken ◽  
Stanimir Georgiev ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Pulmonary Valve ◽  
Therapeutic Option ◽  
Pulmonary Regurgitation ◽  
Right Ventricular Outflow Tract ◽  
Melody Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

Background: The folded valve is a manual shortening of the Melody device, which has been validated as a valuable therapeutic option for the management of dysfunctional right ventricular outflow tracts needing a short valved stent. In this article, we aimed to evaluate, in a multicenter cohort, the mid-term outcomes of patients in whom a percutaneous pulmonary valve implantation was performed using the folded valve technique. Methods: A 2012 to 2018 retrospective multicenter study was performed in 7 European institutions. All patients who benefit from percutaneous pulmonary valve implantation with a folded Melody valve were included. Results: A total of 49 patients (median age, 19 years [range 4–56], 63% male) were included. The primary percutaneous pulmonary valve implantation indication was right ventricular outflow tract stenosis (n=19; 39%), patched native right ventricular outflow tracts were the most common substrate (n=15; 31%). The folded technique was mostly used in short right ventricular outflow tracts (n=28; 57%). Procedural success was 100%. After a median follow-up of 28 months (range, 4–80), folded Melody valve function was comparable to the immediate postimplantation period (mean transvalvular peak velocity=2.6±0.6 versus 2.4±0.6 m/s, P >0.1; only 2 patients had mild pulmonary regurgitation). Incidence rate of valve-related reinterventions was 2.1% per person per year (95% CI, 0.1%–3.9%). The probability of survival without valve-related reinterventions at 36 months was 90% (95% CI, 76%–100%). Conclusions: The folded Melody valve is a safe technique with favorable mid-term outcomes up to 6.5 years after implantation, comparable with the usual Melody valve implantation procedure. Complications and reinterventions rates were low, making this technique relevant in selected patients.

scholarly journals A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: The ‘Folded Melody® Valve’

2014 ◽  
Vol 107 (8-9) ◽  
pp. 487
Author(s):  
Z. Jalal ◽  
S. Malekzadeh-Milani ◽  
M. Hofbeck ◽  
K. Al Najashi ◽  
J.B. Thambo ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Pulmonary Valve ◽  
Implantation Technique ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

scholarly journals Right ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation

2020 ◽  
Vol 113 (2) ◽  
pp. 113-120
Author(s):  
Clement Karsenty ◽  
Sophie Malekzadeh-Milani ◽  
Alain Fraisse ◽  
Marc Gewillig ◽  
Damien Bonnet ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Pulmonary Valve ◽  
Right Ventricular Outflow Tract ◽  
Ventricular Outflow Tract ◽  
Outflow Tract ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

scholarly journals Endocarditis risk following percutaneous pulmonary valve implantation is higher with Melody valve compared to Sapien valve.

2016 ◽  
Vol 8 (5) ◽  
pp. 2-3
Author(s):  
Sebastien Hascoet ◽  
Lucia Mauri ◽  
Caroline Claude ◽  
Emmanuelle Fournier ◽  
Ihab Khatib ◽  
...  
Keyword(s):  
Pulmonary Valve ◽  
Melody Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

scholarly journals Tricuspid Regurgitation Does Not Impact Right Ventricular Remodeling After Percutaneous Pulmonary Valve Implantation

2017 ◽  
Vol 10 (7) ◽  
pp. 701-708 ◽  
Author(s):  
Daniel Tanase ◽  
Peter Ewert ◽  
Stanimir Georgiev ◽  
Christian Meierhofer ◽  
Jelena Pabst von Ohain ◽  
...  
Keyword(s):  
Right Ventricular ◽  
Tricuspid Regurgitation ◽  
Ventricular Remodeling ◽  
Pulmonary Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Right Ventricular Remodeling ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

Emergency surgery for extrinsic coronary compression after percutaneous pulmonary valve implantation

2012 ◽  
Vol 23 (3) ◽  
pp. 463-465 ◽  
Author(s):  
Lucia Mauri ◽  
Alessandro Frigiola ◽  
Gianfranco Butera
Keyword(s):  
Coronary Artery ◽  
Pulmonary Valve ◽  
Fatal Complication ◽  
Extrinsic Compression ◽  
Melody Valve ◽  
Percutaneous Pulmonary Valve Implantation ◽  
Valve Implantation ◽  
Coronary Compression ◽  
Percutaneous Pulmonary Valve ◽  
Pulmonary Valve Implantation

AbstractCoronary artery compression is a rare and potentially fatal complication after percutaneous pulmonary valve implantation. We report on a case of an acute antero-septal non-ST myocardial infarction secondary to the partial laceration of the conduit and the creation of a thrombus giving an extrinsic compression of left anterior descendent coronary artery after Melody valve implantation.

Sign in / Sign up

Export Citation Format

Share Document